- Home
- FNF vs MEDP Comparison
FNF vs MEDP Comparison
Compare FNF & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNF
- MEDP
- Stock Information
- Founded
- FNF 1847
- MEDP 1992
- Country
- FNF United States
- MEDP United States
- Employees
- FNF N/A
- MEDP N/A
- Industry
- FNF Specialty Insurers
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- FNF Finance
- MEDP Health Care
- Exchange
- FNF Nasdaq
- MEDP Nasdaq
- Market Cap
- FNF 16.0B
- MEDP 13.4B
- IPO Year
- FNF N/A
- MEDP 2016
- Fundamental
- Price
- FNF $58.46
- MEDP $490.77
- Analyst Decision
- FNF Strong Buy
- MEDP Hold
- Analyst Count
- FNF 5
- MEDP 11
- Target Price
- FNF $71.20
- MEDP $424.10
- AVG Volume (30 Days)
- FNF 1.0M
- MEDP 320.7K
- Earning Date
- FNF 11-05-2025
- MEDP 10-20-2025
- Dividend Yield
- FNF 3.33%
- MEDP N/A
- EPS Growth
- FNF 16.93
- MEDP 26.42
- EPS
- FNF 3.93
- MEDP 13.46
- Revenue
- FNF $13,634,000,000.00
- MEDP $2,231,787,000.00
- Revenue This Year
- FNF $1.15
- MEDP $19.06
- Revenue Next Year
- FNF $10.81
- MEDP $8.64
- P/E Ratio
- FNF $15.27
- MEDP $36.52
- Revenue Growth
- FNF 7.26
- MEDP 9.94
- 52 Week Low
- FNF $50.61
- MEDP $250.05
- 52 Week High
- FNF $66.72
- MEDP $501.30
- Technical
- Relative Strength Index (RSI)
- FNF 51.35
- MEDP 62.33
- Support Level
- FNF N/A
- MEDP $485.33
- Resistance Level
- FNF $60.97
- MEDP $498.15
- Average True Range (ATR)
- FNF 1.02
- MEDP 11.60
- MACD
- FNF -2.42
- MEDP -1.73
- Stochastic Oscillator
- FNF 95.21
- MEDP 76.38
About FNF FNF Group of Fidelity National Financial Inc.
Fidelity National Financial Inc is a provider of (i) title insurance, escrow and other title-related services, including trust activities, trustee sales guarantees, recordings and reconveyances and home warranty and (ii) transaction services to the real estate and mortgage industries. It operates in three segments: Title, F&G, Corporate and Other. The title segment that derives the majority of revenue consists of the operations of title insurance underwriters and related businesses, which provide title insurance and escrow and other title-related services including trust activities, trustee sales guarantees, and home warranty products. Substantially all of the company's revenue is generated in the United States.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.